Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 29, 2024

BUY
$42.56 - $59.82 $1.31 Million - $1.84 Million
30,744 New
30,744 $1.74 Million
Q3 2023

Oct 23, 2023

SELL
$44.2 - $50.2 $768,991 - $873,379
-17,398 Reduced 75.94%
5,513 $251,000
Q2 2023

Aug 10, 2023

BUY
$31.86 - $67.26 $545,411 - $1.15 Million
17,119 Added 295.56%
22,911 $993,000
Q1 2023

May 11, 2023

SELL
$45.44 - $74.26 $42,350 - $69,210
-932 Reduced 13.86%
5,792 $380,000
Q4 2022

Feb 07, 2023

BUY
$41.39 - $81.0 $13,865 - $27,135
335 Added 5.24%
6,724 $302,000
Q3 2022

Nov 14, 2022

SELL
$72.36 - $113.1 $28,944 - $45,240
-400 Reduced 5.89%
6,389 $462,000
Q2 2022

Jul 19, 2022

SELL
$87.2 - $114.05 $1.27 Million - $1.67 Million
-14,615 Reduced 68.28%
6,789 $728,000
Q1 2022

May 04, 2022

SELL
$94.19 - $124.49 $53,499 - $70,710
-568 Reduced 2.59%
21,404 $2.37 Million
Q4 2021

Jan 31, 2022

BUY
$119.57 - $139.07 $348,546 - $405,389
2,915 Added 15.3%
21,972 $2.81 Million
Q3 2021

Oct 29, 2021

BUY
$109.17 - $142.35 $294,322 - $383,775
2,696 Added 16.48%
19,057 $2.54 Million
Q2 2021

Aug 11, 2021

SELL
$100.34 - $115.69 $253,960 - $292,811
-2,531 Reduced 13.4%
16,361 $1.77 Million
Q1 2021

May 04, 2021

BUY
$101.51 - $125.27 $837,254 - $1.03 Million
8,248 Added 77.49%
18,892 $1.99 Million
Q4 2020

Feb 11, 2021

SELL
$85.88 - $105.36 $46,203 - $56,683
-538 Reduced 4.81%
10,644 $1.11 Million
Q3 2020

Nov 05, 2020

BUY
$72.74 - $92.5 $460,516 - $585,617
6,331 Added 130.51%
11,182 $957,000
Q2 2020

Aug 12, 2020

BUY
$48.02 - $79.04 $35,438 - $58,331
738 Added 17.94%
4,851 $355,000
Q1 2020

May 11, 2020

SELL
$36.95 - $62.95 $19,953 - $33,993
-540 Reduced 11.61%
4,113 $213,000
Q4 2019

Feb 05, 2020

BUY
$47.06 - $56.64 $218,970 - $263,545
4,653 New
4,653 $261,000
Q3 2019

Oct 30, 2019

SELL
$47.45 - $58.05 $201,140 - $246,073
-4,239 Closed
0 $0
Q2 2019

Jul 19, 2019

SELL
$39.26 - $54.21 $34,823 - $48,084
-887 Reduced 17.3%
4,239 $229,000
Q1 2019

May 13, 2019

BUY
$29.84 - $43.92 $152,959 - $225,133
5,126 New
5,126 $208,000
Q4 2018

Feb 11, 2019

SELL
$29.95 - $46.34 $133,606 - $206,722
-4,461 Closed
0 $0
Q3 2018

Nov 06, 2018

BUY
$40.12 - $45.55 $178,975 - $203,198
4,461 New
4,461 $203,000

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11.4B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Commonwealth Equity Services, LLC Portfolio

Follow Commonwealth Equity Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Equity Services, LLC with notifications on news.